Suppr超能文献

一组暴露于非甾体抗炎药的危重症患者的急性肾损伤

Acute Kidney Injury in a Cohort of Critical Illness Patients Exposed to Non-Steroidal Anti-Inflammatory Drugs.

作者信息

Oliveros Henry, Buitrago Giancarlo

机构信息

PhD Program in Clinical Epidemiology, Department of Clinical Epidemiology and Biostatistics, Pontificia Universidad Javeriana, Bogotá 110231, Colombia.

School of Medicine, Universidad de La Sabana, Chía 250001, Colombia.

出版信息

Pharmaceuticals (Basel). 2022 Nov 14;15(11):1409. doi: 10.3390/ph15111409.

Abstract

To determine whether non-steroidal anti-inflammatory drug (NSAIDs) exposure prior to intensive care unit (ICU) admission affects the development of acute kidney injury (AKI) with renal replacement therapy (RRT). An administrative database is used to establish a cohort of patients who were admitted to the ICU. The exposure to NSAIDs that the patients had before admission to the ICU is determined. Demographic variables, comorbidities, AKI diagnoses requiring RRT, and pneumonia during the ICU stay are also measured. Multivariate logistic regression and inverse probability weighting (IPW) are used to calculate risks of exposure to NSAIDs for patients with AKI requiring RRT. In total, 96,235 patients were admitted to the ICU, of which 16,068 (16.7%) were exposed to NSAIDs. The incidence of AKI with RRT was 2.71% for being exposed to NSAIDs versus 2.24% for those not exposed (p < 0.001). For the outcome of AKI, the odds ratio weighted with IPW was 1.28 (95% CI: 1.15−1.43), and for the outcome of pneumonia as a negative control, the odds ratio was 1.07 (95% CI: 0.98−1.17). The impact of prior exposure to NSAIDs over critically ill patients in the development of AKI is calculated as 8 patients per 1000 exposures. The negative control with the same sources of bias did not show an association with NSAID exposure.

摘要

为确定重症监护病房(ICU)入院前使用非甾体抗炎药(NSAIDs)是否会影响需要肾脏替代治疗(RRT)的急性肾损伤(AKI)的发生。利用一个管理数据库建立了一组入住ICU的患者队列。确定患者在入住ICU之前使用NSAIDs的情况。还测量了人口统计学变量、合并症、需要RRT的AKI诊断以及ICU住院期间的肺炎情况。采用多因素逻辑回归和逆概率加权法(IPW)计算需要RRT的AKI患者使用NSAIDs的风险。共有96235例患者入住ICU,其中16068例(16.7%)使用过NSAIDs。使用NSAIDs的患者中需要RRT的AKI发生率为2.71%,未使用NSAIDs的患者为2.24%(p<0.001)。对于AKI结局,经IPW加权的比值比为1.28(95%CI:1.15 - 1.43),对于作为阴性对照的肺炎结局,比值比为1.07(95%CI:0.98 - 1.17)。计算得出,NSAIDs既往暴露对危重症患者发生AKI的影响为每1000次暴露中有8例患者。具有相同偏倚来源的阴性对照未显示与NSAIDs暴露有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5602/9693114/1104ec7c8e41/pharmaceuticals-15-01409-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验